PLATINUM AGENTS AND SECONDARY MYELOID LEUKAEMIA: TWO CASES TREATED ONLY WITH PLATINUM‐BASED DRUGS
暂无分享,去创建一个
M. Gore | D. Catovsky | T. Min | G. Swansbury | R. Powles | M. Elebute | N. Philpott | J. Treleaven | J. Treleaven | M. Dainton
[1] J. Reilly,et al. Acute promyelocytic leukaemia after treatment for seminoma with carboplatin , 1994, The Lancet.
[2] B. Johansson,et al. Secondary chromosomal abnormalities in acute leukemias. , 1994, Leukemia.
[3] J. Rowley,et al. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. , 1994, Blood.
[4] S. Larsen,et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. , 1993, Leukemia.
[5] M. Hussain,et al. Myelodysplastic syndrome after cisplatin therapy , 1993, Cancer.
[6] L. Shulman. The biology of alkylating-agent cellular injury. , 1993, Hematology/oncology clinics of North America.
[7] K. Ballen,et al. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes. , 1993, Hematology/Oncology Clinics of North America.
[8] L. Robison,et al. Second tumors after treatment of childhood malignancies. , 1993, Hematology/oncology clinics of North America.
[9] M. Ro̸rth,et al. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Piver,et al. Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park. , 1992, European journal of gynaecological oncology.
[11] F. Behm,et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. , 1991, The New England journal of medicine.
[12] S. Devereux. Therapy associated leukaemia. , 1991, Blood reviews.
[13] J. Pedersen‐Bjergaard,et al. Two different classes of therapy-related and de-novo acute myeloid leukemia? , 1991, Cancer genetics and cytogenetics.
[14] H. Gralnick,et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO) , 1991, British journal of haematology.
[15] F. Behm,et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. , 1989, The New England journal of medicine.
[16] D. Longo,et al. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. , 1988, Blood.
[17] H. Kantarjian,et al. Therapy-related leukemia and myelodysplastic syndrome. , 1987, Seminars in oncology.
[18] R. Hoover,et al. Leukemia after therapy with alkylating agents for childhood cancer. , 1987, Journal of the National Cancer Institute.
[19] R. Weiss,et al. Acute leukemia following cisplatin for bladder cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[21] D. Arthur,et al. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. , 1985, Blood.